Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats

Psychopharmacology

Volumn 219, Issue 1, 2012, Pages 123-135

  Collins, Gregory T ^a   Cunningham, Alyssa R ^a   Chen, Jianyong ^a   Wang, Shaomeng ^a   Newman, Amy H ^b   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cocaine; Conditioned; Dopamine receptor; Drug abuse; Operant; Reinforcement; Self administration

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; PRAMIPEXOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG MECHANISM; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RESPONSE TIME; SENSITIVITY ANALYSIS; STIMULUS RESPONSE;

ANIMALS; BENZOTHIAZOLES; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE;

EID: 84856626488     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2382-5     Document Type: Article

References (60)

1. 3H]dopamine uptake inhibition produced by selected partial opioid agonists Behav Pharmacol 12 225 235 11548108 10.1097/00008877-200107000-00001 1:CAS:528:DC%2BD3MXmvV2ksLg%3D (Pubitemid 32730504)
2. RJ Beninger DR Hanson AG Phillips 1981 The acquisition of responding with conditioned reinforcement: effects of cocaine, (+)-amphetamine and pipradrol Br J Pharmacol 74 149 154 6115694 1:CAS:528:DyaL38XntV0%3D (Pubitemid 12196870)
3. V Boulougouris A Castane TW Robbins 2009 Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior Psychopharmacology (Berl) 202 611 620 10.1007/s00213-008-1341-2 1:CAS:528:DC%2BD1cXht1aisLfF
4. SB Caine GF Koob 1993 Modulation of cocaine self-administration in the rat through D-3 dopamine receptors Science 260 1814 1816 8099761 10.1126/science.8099761 1:CAS:528:DyaK3sXkvVGrtLg%3D
5. SB Caine SS Negus NK Mello S Patel L Bristow J Kulagowski D Vallone A Saiardi E Borrelli 2002 Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists J Neurosci 22 2977 2988 11923462 1:CAS:528:DC%2BD38Xis1WjsrY%3D (Pubitemid 37465846)
6. LP Carter RR Griffiths 2009 Principles of laboratory assessment of drug abuse liability and implications for clinical development Drug Alcohol Depend 105 Suppl 1 S14 S25 19443137 10.1016/j.drugalcdep.2009.04.003 1:CAS:528:DC%2BD1MXht1yjurbF
7. L Cervo A Cocco C Petrella CA Heidbreder 2007 Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat Int J Neuropsychopharmacol 10 167 181 16426478 10.1017/S1461145705006449 1:CAS:528:DC%2BD2sXhs1Cqsrg%3D
8. GT Collins JH Woods 2007 Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat J Pharmacol Exp Ther 323 599 605 17675585 10.1124/jpet.107.123042 1:CAS:528:DC%2BD2sXht1ynsb7L (Pubitemid 350005111)
9. GT Collins JH Woods 2009 Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats Behav Pharmacol 20 492 504 19696656 10.1097/FBP.0b013e328330ad9b 1:CAS:528:DC%2BD1MXhtV2qtrzM
10. GT Collins JM Witkin AH Newman KA Svensson P Grundt J Cao JH Woods 2005 Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior J Pharmacol Exp Ther 314 310 319 15833897 10.1124/jpet.105.085472 1:CAS:528:DC%2BD2MXmtVeju7Y%3D (Pubitemid 41058268)
11. GT Collins AH Newman P Grundt KC Rice SM Husbands C Chauvignac J Chen S Wang JH Woods 2007 Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists Psychopharmacology (Berl) 193 159 170 10.1007/s00213-007-0766-3 1:CAS:528:DC%2BD2sXntFGqt7k%3D (Pubitemid 47025018)
12. GT Collins DM Calinski AH Newman P Grundt JH Woods 2008 Food restriction alters N′-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects J Pharmacol Exp Ther 325 691 697 18305018 10.1124/jpet.107.133181 1:CAS:528:DC%2BD1cXlsVOjtLw%3D (Pubitemid 351574782)
13. GT Collins A Truccone F Haji-Abdi AH Newman P Grundt KC Rice SM Husbands BM Greedy C Enguehard-Gueiffier A Gueiffier J Chen S Wang JL Katz DK Grandy RK Sunahara JH Woods 2009 Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice J Pharmacol Exp Ther 329 210 217 19136638 10.1124/jpet.108.144048 1:CAS:528:DC%2BD1MXksVKnu78%3D
14. GT Collins YN Truong B Levant J Chen S Wang JH Woods 2011 Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D(3) and D(2) receptor sensitivity Psychopharmacology (Berl) 215 609 620 10.1007/s00213-010-2154-7 1:CAS:528:DC%2BC3MXhtVGgtA%3D%3D
15. JW Dalley TD Fryer L Brichard ES Robinson DE Theobald K Laane Y Pena ER Murphy Y Shah K Probst I Abakumova FI Aigbirhio HK Richards Y Hong JC Baron BJ Everitt TW Robbins 2007 Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement Science 315 1267 1270 17332411 10.1126/science.1137073 1:CAS:528:DC%2BD2sXitFChsrk%3D (Pubitemid 46364262)
16. TJ De Vries AN Schoffelmeer R Binnekade LJ Vanderschuren 1999 Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration Psychopharmacology (Berl) 143 254 260 10.1007/s002130050944 (Pubitemid 29204978)
17. TJ De Vries AN Schoffelmeer R Binnekade H Raaso LJ Vanderschuren 2002 Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization Neuropsychopharmacology 26 18 26 11751029 10.1016/S0893-133X(01)00293-7 (Pubitemid 34075273)
18. P Di Ciano RJ Underwood JJ Hagan BJ Everitt 2003 Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A Neuropsychopharmacology 28 329 3382 12589386 10.1038/sj.npp.1300148
19. EC Donny N Chaudhri AR Caggiula FF Evans-Martin S Booth MA Gharib LA Clements AF Sved 2003 Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement Psychopharmacology (Berl) 169 68 76 10.1007/s00213-003-1473-3 1:CAS:528:DC%2BD3sXmsFaqsr0%3D (Pubitemid 37088616)
20. E Driver-Dunckley J Samanta M Stacy 2003 Pathological gambling associated with dopamine agonist therapy in Parkinson's disease Neurology 61 422 423 12913220 1:STN:280:DC%2BD3sznslyjsQ%3D%3D (Pubitemid 36975988)
21. ED Driver-Dunckley BN Noble JG Hentz VG Evidente JN Caviness J Parish L Krahn CH Adler 2007 Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome Clin Neuropharmacol 30 249 255 17909302 10.1097/wnf.0b013e31804c780e 1:CAS:528:DC%2BD2sXhtFSntb7M (Pubitemid 47511504)
22. AH Evans R Katzenschlager D Paviour JD O'Sullivan S Appel AD Lawrence AJ Lees 2004 Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome Mov Disord 19 397 405 15077237 10.1002/mds.20045 (Pubitemid 38559642)
23. BJ Everitt D Belin D Economidou Y Pelloux JW Dalley TW Robbins 2008 Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction Philos Trans R Soc Lond B Biol Sci 363 3125 3135 18640910 10.1098/rstb.2008.0089
24. P Grundt EE Carlson J Cao CJ Bennett E McElveen M Taylor RR Luedtke AH Newman 2005 Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3- dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor J Med Chem 48 839 848 15689168 10.1021/jm049465g 1:CAS:528:DC%2BD2MXjtFGisA%3D%3D (Pubitemid 40209106)
25. P Grundt KM Prevatt J Cao M Taylor CZ Floresca JK Choi BG Jenkins RR Luedtke AH Newman 2007 Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl) piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents J Med Chem 50 4135 4146 17672446 10.1021/jm0704200 1:CAS:528: DC%2BD2sXosVWitLY%3D (Pubitemid 47301745)
26. A Hamidovic UJ Kang H de Wit 2008 Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers J Clin Psychopharmacol 28 45 51 18204340 10.1097/jcp.0b013e3181602fab 1:CAS:528:DC%2BD1cXnsFOitg%3D%3D
27. M Haney RW Foltin MW Fischman 1998 Effects of pergolide on intravenous cocaine self-administration in men and women Psychopharmacology (Berl) 137 15 24 10.1007/s002130050588 1:CAS:528:DyaK1cXjt12lsro%3D (Pubitemid 28224999)
28. CA Heidbreder AH Newman 2010 Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders Ann N Y Acad Sci 1187 4 34 20201845 10.1111/j.1749-6632.2009.05149.x 1:CAS:528:DC%2BC3cXks1Snurc%3D
29. CA Heidbreder EL Gardner ZX Xi PK Thanos M Mugnaini JJ Hagan CR Ashby Jr 2005 The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence Brain Res Brain Res Rev 49 77 105 15960988 10.1016/j.brainresrev.2004.12.033 1:CAS:528:DC%2BD2MXlt1Ghu7k%3D (Pubitemid 40800164)
30. AE Higley K Spiller P Grundt AH Newman SW Kiefer ZZ Xi EL Gardner 2010 PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats J Psychopharmacol 25 263 273 20142301 10.1177/0269881109358201
31. AJ Holman 2009 Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia J Gambl Stud 25 425 431 19241148 10.1007/s10899-009-9123-2
32. Institute of Laboratory Animal Research CoLS, National Research Council (1996) Guide for the care and use of laboratory animals, 7th edition. The National Academies Press
33. D Joel A Avisar J Doljansky 2001 Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol Behav Neurosci 115 1291 1300 11770060 10.1037/0735-7044.115.6.1291 1:CAS:528:DC%2BD38Xks1WqsQ%3D%3D (Pubitemid 33139136)
34. Khaled MA, Farid Araki K, Li B, Coen KM, Marinelli PW, Varga J, Gaal J, Le Foll B (2009) The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int J Neuropsychopharmacol: 1-10
35. K Kumor M Sherer J Jaffe 1989 Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine Pharmacol Biochem Behav 33 829 837 2616602 10.1016/0091-3057(89)90478-4 1:CAS:528:DyaK3cXhs1Wmuw%3D%3D (Pubitemid 19284296)
36. DD Kurylo 2004 Effects of quinpirole on operant conditioning: perseveration of behavioral components Behav Brain Res 155 117 124 15325785 10.1016/j.bbr.2004.04.015 1:CAS:528:DC%2BD2cXmvFWktLk%3D (Pubitemid 39119972)
37. DD Kurylo S Tanguay 2003 Effects of quinpirole on behavioral extinction Physiol Behav 80 1 7 14568302 10.1016/S0031-9384(03)00218-X 1:CAS:528: DC%2BD3sXotVyku78%3D (Pubitemid 37249367)
38. MJ Millan A Dekeyne JM Rivet T Dubuffet G Lavielle M Brocco 2000 S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626 J Pharmacol Exp Ther 293 1063 1073 10869411 1:CAS:528: DC%2BD3cXjslekt74%3D (Pubitemid 30417877)
39. MJ Millan L Maiofiss D Cussac V Audinot JA Boutin A Newman-Tancredi 2002 Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J Pharmacol Exp Ther 303 791 804 12388666 10.1124/jpet.102.039867 1:CAS:528:DC%2BD38XotlCnsL8%3D (Pubitemid 35231256)
40. D Morgan KA Grant HD Gage RH Mach JR Kaplan O Prioleau SH Nader N Buchheimer RL Ehrenkaufer MA Nader 2002 Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration Nat Neurosci 5 169 174 11802171 10.1038/nn798 1:CAS:528:DC%2BD38XhtFKlsL0%3D (Pubitemid 34121585)
41. AH Newman P Grundt MA Nader 2005 Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents J Med Chem 48 3663 3679 15916415 10.1021/jm040190e 1:CAS:528:DC%2BD2MXjtl2nur0%3D (Pubitemid 40776839)
42. EC O'Connor K Chapman P Butler AN Mead 2011 The predictive validity of the rat self-administration model for abuse liability Neurosci Biobehav Rev 35 912 938 21036191 10.1016/j.neubiorev.2010.10.012
43. SS O'Sullivan AH Evans AJ Lees 2009 Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management CNS Drugs 23 157 170 19173374 10.2165/00023210-200923020-00005
44. M Pilla S Perachon F Sautel F Garrido A Mann CG Wermuth JC Schwartz BJ Everitt P Sokoloff 1999 Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 400 371 375 10432116 10.1038/22560 1:CAS:528:DyaK1MXkvFOntr0%3D (Pubitemid 29344203)
45. NR Richardson DC Roberts 1996 Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J Neurosci Methods 66 1 11 8794935 10.1016/0165-0270(95)00153-0 1:CAS:528:DyaK28Xkt1Olsb4%3D (Pubitemid 26180064)
46. TW Robbins 1976 Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs Nature 264 57 59 12471 10.1038/264057a0 1:STN:280:DyaE2s%2FnslWltQ%3D%3D
47. TW Robbins 1978 The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine Psychopharmacology (Berl) 58 79 87 10.1007/BF00426794 1:CAS:528:DyaE1cXltVSju7Y%3D (Pubitemid 8356986)
48. TW Robbins GF Koob 1978 Pipradrol enhances reinforcing properties of stimuli paired with brain stimulation Pharmacol Biochem Behav 8 219 222 26063 10.1016/0091-3057(78)90308-8 1:CAS:528:DyaE1cXkvF2qsro%3D (Pubitemid 8313394)
49. S Schenk B Partridge 2001 Influence of a conditioned light stimulus on cocaine self-administration in rats Psychopharmacology (Berl) 154 390 396 10.1007/s002130000608 1:CAS:528:DC%2BD3MXjsFCrsro%3D (Pubitemid 32260898)
50. DW Self WJ Barnhart DA Lehman EJ Nestler 1996 Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists Science 271 1586 1589 8599115 10.1126/science.271.5255.1586 1:CAS:528:DyaK28XhslSjsbc%3D (Pubitemid 26097217)
51. P Terry JM Witkin JL Katz 1994 Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine J Pharmacol Exp Ther 270 1041 1048 7932151 1:CAS:528:DyaK2cXmslWqtLY%3D (Pubitemid 24315218)
52. ND Volkow GJ Wang JS Fowler J Logan SJ Gatley A Gifford R Hitzemann YS Ding N Pappas 1999 Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels Am J Psychiatry 156 1440 1443 10484959 1:STN:280:DyaK1MvhsVKitw%3D%3D (Pubitemid 29416545)
53. V Voon SH Fox 2007 Medication-related impulse control and repetitive behaviors in Parkinson disease Arch Neurol 64 1089 1096 17698698 10.1001/archneur.64.8.1089 (Pubitemid 47258066)
54. V Voon K Hassan M Zurowski M de Souza T Thomsen S Fox AE Lang J Miyasaki 2006 Prevalence of repetitive and reward-seeking behaviors in Parkinson disease Neurology 67 1254 1257 16957130 10.1212/01.wnl.0000238503.20816.13 1:STN:280:DC%2BD28rpvFGhtw%3D%3D (Pubitemid 44563838)
55. V Voon MN Potenza T Thomsen 2007 Medication-related impulse control and repetitive behaviors in Parkinson's disease Curr Opin Neurol 20 484 492 17620886 10.1097/WCO.0b013e32826fbc8f (Pubitemid 47051998)
56. D Weintraub 2008 Dopamine and impulse control disorders in Parkinson's disease Ann Neurol 64 Suppl 2 S93 S100 19127573
57. D Weintraub MN Potenza 2006 Impulse control disorders in Parkinson's disease Curr Neurol Neurosci Rep 6 302 306 16822350 10.1007/s11910-006-0022-y (Pubitemid 44069969)
58. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67589-595
59. Wolterink G, Phillips G, Cador M, Donselaar-Wolterink I, Robbins TW, Everitt BJ (1993) Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacology (Berl) 110355-364
60. WL Woolverton LI Goldberg JZ Ginos 1984 Intravenous self-administration of dopamine receptor agonists by rhesus monkeys J Pharmacol Exp Ther 230 678 683 6332190 1:CAS:528:DyaL2cXlvVCks74%3D (Pubitemid 14040389)